跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
S-73
首页
药物
S-73
S-73
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Preparation of clamycin 2'-monopropionate dodecylsulfate and its medicinal application
CN 1176935 C
申请人: WANG XINHUA
优先权: 2000
CN
Treatment of elevated plasma homocysteine
EP 1396537 A1
申请人: AVIDIS SA
优先权: 2002
EP
BIDENTATE MOTIF AND METHODS OF USE
US 2007219117 A1
申请人: MEDVET SCIENCE PTY LTD
优先权: 2003
US
Anticancer epiphyte composition and method of making the same
CN 101095699 A
申请人: YONG CAI
优先权: 2006
CN
N-(1-Phthalazin-1-yl-piperidin-4-yl)-amides as EP2-receptor modulators
EP 1900731 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2006
EP
N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators
EP 1903038 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2006
EP
Indolyl alkyl thieno-pyrimidyl amines as modulators of EP2 receptors
EP 2014662 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2007
EP
Chitin-glucan complex, its preparation, and uses
CN 106572959 A
申请人: PHARMA73 S A
优先权: 2014
CN
Method for conducting microwave sterilization on honeysuckle flowers
CN 106474173 A
申请人: SICHUAN XUYANG PHARMACEUTICAL CO LTD
优先权: 2016
CN
ANAVEX2-73 FOR THE TREATMENT OF ALZHEIMER S DISEASE
EP 4537846 A2
申请人: ANAVEX LIFE SCIENCES CORP
优先权: 2017
EP
第 1 / 2 页
上一页
下一页
药物
反馈